This review covers current treatments in metastatic hormone-sensitive prostate cancer, Enzalutamide background and summaries of the ARCHES and ENZAMET trials.
The review includes guiding commentary from Professor Ian Davis, a medical oncologist and Professor of Medicine and Head of the Eastern Health Clinical School, Monash University and Eastern Health, in Melbourne, Australia
Please login below to download this issue (PDF)